Skip to main content

Table 4 Prescription of monotherapies for comorbidities

From: Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study

Antihypertensives

Total

Without comorbidities

Comorbidities3

   

Diabetes

mellitus

Renal

insufficiency

Hypercholesterolaemia

CHD

Post

myocardial

infarction

Heart

failure

Stroke

Obesity

Asthma/COPD

 

[N (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

[n (%)]

CCB1

527 (17.1)

88 (18.6)

55 (15.9)

26 (20.5)

97 (15.4)

58 (14.5)

12 (20.0)

12 (18.8)

56 (20.4)

47 (13.6)

76 (20.8)

   - with CAM2

14

5

2

-

1

1

-

-

2

-

3

Diuretic

514 (16.7)

77 (16.2)

46 (13.3)

27 (21.3)

58 (9.2)

73 (18.3)

14 (23.3)

15 (23.4)

54 (19.6)

63 (18.2)

87 (23.8)

   - with CAM

41

19

2

1

4

3

-

-

2

5

5

Beta-blocker

882 (28.7)

151 (31.9)

113 (32.8)

20 (15.7)

225 (35.7)

114 (28.5)

11 (18.3)

8 (12.5)

61 (22.2)

96 (27.7)

83 (22.7)

   - with CAM

36

13

3

-

8

3

-

-

4

2

3

ACE inhibitor

729 (23.6)

94 (19.8)

75 (21.7)

37 (29.1)

147 (23.3)

113 (28.3)

17 (28.3)

21 (32.8)

79 (28.7)

85 (24.6)

61 (16.7)

   - with CAM

33

6

4

3

6

9

-

-

2

2

1

Angiotensin II antagonist

363 (11.8)

64 (13.5)

50 (14.5)

11 (8.7)

86 (13.6)

38 (9.5)

5 (8.3)

7 (10.9)

18 (6.5)

48 (13.9)

36 (9.8)

   - with CAM

23

8

1

1

4

1

-

-

1

4

3

Alpha-1 blocker

20 (0.7)

-

1 (0.3)

1 (0.8)

4 (0.6)

1 (0.3)

1 (1.7)

-

3 (1.1)

3 (0.9)

6 (1.6)

   - with CAM

-

-

-

-

-

-

-

-

-

-

-

Antiadrenergic agent

44 (1.4)

-

5 (1.4)

5 (3.9)

14 (2.2)

3 (0.8)

-

1 (1.6)

4 (1.5)

4 (1.2)

8 (2.2)

   - with CAM

1

-

-

-

-

-

-

-

-

-

1

Total

3088 (100)

474 (100)

345 (100)

127 (100)

631 (100)

400 (100)

60 (100)

64 (100)

275 (100)

346 (100)

366 (100)

  1. 1 Calcium channel blocker, 2 complementary remedy, 3 double entries possible